Skip to main content

Mr. Gilliam

Equibles does not estimate personal net worth.

Get an email with a short summary when 10x Genomics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TXG alerts

About Mr. Gilliam

Mr. Gilliam is recorded as Chairman at 10x Genomics, Inc. (TXG) since October 30, 2026. 10x Genomics, Inc. reported in an 8-K filed November 2, 2026 that Mr. Gilliam was appointed Chair of the Audit Committee of the Board of Directors, effective October 30, 2026. 10x Genomics, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at 10x Genomics, Inc. includes Serge Saxonov (CEO and Board Member), John R. Stuelpnagel (Chairman and Board Member), Adam S. Taich (CFO) and 7 others.

“On October 30, 2026, Mr. Gilliam was appointed Chair of the Audit Committee of the Board of Directors, for which he shall receive an annual retainer of $25,000 (prorated as necessary).”
10x Genomics, Inc. Form 8-K, filed November 2, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at 10x Genomics, Inc.

Recent activity